BIONOMICS LIMITED - Announcements

Currently unlisted. Add to my watchlist

Bionomics Limited (Bionomics) is an Australia-bases clinical-stage biopharmaceutical... Bionomics Limited (Bionomics) is an Australia-bases clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of novel, ion channel targeting drug candidates designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders. The Company operates in drug development segment in Australia. The Company is advancing its lead drug candidate, BNC210, which is an oral, proprietary, selective negative allosteric modulator of the a7 nicotinic acetylcholine receptor, for the acute treatment of Social Anxiety Disorder (SAD) and chronic treatment of Post-Traumatic Stress Disorder (PTSD). The Company has two drugs in early-stage clinical trials for the treatment of cognitive deficits in Alzheimer’s disease and other central nervous system conditions.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

BNO	Resignation of Director - M Kaye		31/12/21	178.65KB	Share
BNO	Becoming a substantial holder		24/12/21	520.23KB	Share
BNO	Change of Director's Interest Notice AF		22/12/21	255.09KB	Share
BNO	Change of Director's Interest Notice EDS		22/12/21	284.59KB	Share
BNO	Notification regarding unquoted securities - BNO		22/12/21	26.2KB	Share
BNO	Change in substantial holding		22/12/21	198.26KB	Share
BNO	Bionomics Announces Closing of IPO in the US		21/12/21	106.77KB	Share
BNO	Cleansing Notice		20/12/21	140.7KB	Share
BNO	Application for quotation of securities - BNO		17/12/21	23.16KB	Share
BNO	Proposed issue of securities - BNO		16/12/21	27.84KB	Share
BNO	Bionomics Announces Pricing of IPO in the US	PRICE SENSITIVE	16/12/21	108.41KB	Share
BNO	Trading Halt	PRICE SENSITIVE	16/12/21	221.5KB	Share
BNO	Pause in Trading	PRICE SENSITIVE	16/12/21	114.01KB	Share
BNO	Notification of cessation of securities - BNO		14/12/21	22KB	Share
BNO	Bionomics Announces Launch of Proposed IPO in the US	PRICE SENSITIVE	14/12/21	186.82KB	Share
BNO	2021 New Constitution		02/12/21	1.2MB	Share
BNO	2021 AGM Results of Meeting		02/12/21	182.45KB	Share
BNO	2021 AGM Executive Chairman's Presentation	PRICE SENSITIVE	02/12/21	929.59KB	Share
BNO	Fast Track Designation for BNC210 in Social Anxiety Disorder	PRICE SENSITIVE	01/12/21	194.35KB	Share
BNO	Notification of cessation of securities - BNO		30/11/21	21.51KB	Share
BNO	BNO Files Registration Statement for Proposed IPO in the US	PRICE SENSITIVE	23/11/21	178.1KB	Share
BNO	Update on Possible Capital Distribution	PRICE SENSITIVE	19/11/21	85.19KB	Share
BNO	Bionomics Receives ASX Waiver from LR 10.13.5		18/11/21	176.93KB	Share
BNO	Section 708A Notice		11/11/21	159.37KB	Share
BNO	Application for quotation of securities - BNO		11/11/21	24.68KB	Share
BNO	FDA Clears BNC210 Ph2 Social Anxiety Disorder IND (PREVAIL)		01/11/21	209.94KB	Share
BNO	2021 Notice of AGM/Proxy Form		01/11/21	1.64MB	Share
BNO	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/10/21	245.77KB	Share
BNO	Jobkeeper Payments Notification		29/10/21	199.15KB	Share
BNO	2021 Corporate Governance Statement and Appendix 4G		29/10/21	669.96KB	Share
BNO	2021 Annual Report		29/10/21	4.09MB	Share
BNO	Closing Date for Nomination of Director		14/10/21	172.15KB	Share
BNO	Notification of cessation of securities - BNO		07/10/21	21.54KB	Share
BNO	BNO prepares BNC210 for start of Phase 2 Acute SAD trial	PRICE SENSITIVE	20/09/21	186.76KB	Share
BNO	Cleansing Notice		02/09/21	159.95KB	Share
BNO	Application for quotation of securities - BNO		01/09/21	24.83KB	Share
BNO	Correction to Appendix 4E	PRICE SENSITIVE	31/08/21	196.94KB	Share
BNO	Full Year Statutory Accounts FY2021		25/08/21	1.04MB	Share
BNO	Preliminary Final Report FY2021 App 4E and Announcement	PRICE SENSITIVE	25/08/21	262.97KB	Share
BNO	BNO Announces Planned Capital Distribution to Shareholders	PRICE SENSITIVE	02/08/21	187.58KB	Share
BNO	BNO Announces Plans to Conduct U.S. Initial Public Offering	PRICE SENSITIVE	02/08/21	162.74KB	Share
BNO	Quarterly Activities and Cashflow Report	PRICE SENSITIVE	29/07/21	247.97KB	Share
BNO	Final Director's Interest Notice		19/07/21	244.37KB	Share
BNO	BNO Initiates Phase 2b ATTUNE Study of BNC210 in PTSD	PRICE SENSITIVE	06/07/21	237.02KB	Share
BNO	Initial Director's Interest Notice M. Davies		01/07/21	157.83KB	Share
BNO	Notification of cessation of securities - BNO		01/07/21	22.15KB	Share
BNO	Executive Chairman - New Employment Agreement		01/07/21	110.48KB	Share
BNO	Appointment and Resignation of Director		01/07/21	93.71KB	Share
BNO	Change of Telephone Number		18/06/21	91.17KB	Share
BNO	Change of Address		07/06/21	92.08KB	Share
BNO	Cleansing Notice		04/06/21	149.37KB	Share
BNO	Appendix 2A		03/06/21	299.39KB	Share
BNO	Corporate Presentation May 2021		25/05/21	2.7MB	Share
BNO	Bionomics BNC210 Expansion into Social Anxiety Disorder		10/05/21	158.09KB	Share
BNO	Bionomics Announces Early Repayment of Debt	PRICE SENSITIVE	03/05/21	167.1KB	Share
BNO	Quarterly Cashflow Report Mar 2021	PRICE SENSITIVE	23/04/21	334.57KB	Share
BNO	Change in substantial holding		14/04/21	346.64KB	Share
BNO	Appendix 3Y D Wilson		14/04/21	288.96KB	Share
BNO	Change in substantial holding		12/04/21	128.96KB	Share
BNO	Cleansing Notice - Concurrent Placement		08/04/21	147.77KB	Share
BNO	Appendix 2A - Concurrent Placement		08/04/21	298.63KB	Share
BNO	Appendix 2A - Entitlement Offer		08/04/21	298.76KB	Share
BNO	Change of Company Secretary		08/04/21	113.7KB	Share
BNO	Results of Entitlement Offer and Concurrent Placement	PRICE SENSITIVE	06/04/21	174.33KB	Share
BNO	Change of Company Secretary		24/03/21	79.57KB	Share
BNO	Proposed issue of Securities - BNO		18/03/21	24.44KB	Share
BNO	Concurrent Placement with Entitlement Offer to be Conducted	PRICE SENSITIVE	17/03/21	86.39KB	Share
BNO	Bionomics Completes Despatch of Entitlement Offer Booklet		16/03/21	89.55KB	Share
BNO	BNO at H.C. Wainwright Global Life Sciences Conference		08/03/21	90.51KB	Share
BNO	Proposed issue of Securities - BNO		08/03/21	28.05KB	Share
BNO	Entitlement Offer Notification to Option Holders		08/03/21	125.43KB	Share
BNO	Ineligible Shareholder letter		08/03/21	146.64KB	Share
BNO	Bionomics Ltd Entitlement Offer Booklet	PRICE SENSITIVE	08/03/21	419.83KB	Share
BNO	Cleansing Notice		08/03/21	83.69KB	Share
BNO	Bionomics Ltd Announces Non-Renounceable Entitlement Offer	PRICE SENSITIVE	08/03/21	99.68KB	Share
BNO	Change in substantial holding		05/03/21	100.81KB	Share
BNO	Change in substantial holding		04/03/21	1.15MB	Share
BNO	Appendix 2A		02/03/21	280.51KB	Share
BNO	Cleansing Notice		02/03/21	76.78KB	Share
BNO	Completion of Placement	PRICE SENSITIVE	02/03/21	86.73KB	Share
BNO	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/21	491.21KB	Share
BNO	Change in substantial holding		24/02/21	572.93KB	Share
BNO	Positive BNC210 PK Results for Solid Dose Formulation	PRICE SENSITIVE	22/02/21	194.29KB	Share
BNO	Bionomics and EmpathBio Joint Feasibility Assessment		17/02/21	143.48KB	Share
BNO	Notification of Change in Auditor		12/02/21	86.98KB	Share
BNO	Proposed issue of Securities - BNO		09/02/21	24.49KB	Share
BNO	$16 Million Capital Raise to Progress BNC210 PTSD Trial	PRICE SENSITIVE	09/02/21	104.81KB	Share
BNO	Response to ASX Price Query	PRICE SENSITIVE	05/02/21	263.82KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/21	360.92KB	Share
BNO	BNC105 / Nivolumab Treatment Completed in Phase 2 Trial		20/01/21	133.92KB	Share
BNO	Publication of Positive BNC210 Phase 2a Data in GAD Patients		18/01/21	133.81KB	Share
BNO	BNO Presenting at H.C. Wainwright BioConnect 2021 Conference		07/01/21	89.99KB	Share
BNO	BNO Initiates 7-Day Dosing Pharmacokinetic Study of BNC210	PRICE SENSITIVE	04/01/21	93.64KB	Share
BNO	Lapse of Employee Share Options & Warrants		18/12/20	81.21KB	Share
BNO	Appendix 3Y		24/11/20	161.6KB	Share
BNO	Final Director's Interest Notice		20/11/20	151.61KB	Share
BNO	Results of Meeting		20/11/20	151.86KB	Share
BNO	Executive Chairmans 2020 AGM Presentation		20/11/20	805.2KB	Share
BNO	Bionomics Licenses Drug Candidate BNC101 to Carina Biotech	PRICE SENSITIVE	19/11/20	127.88KB	Share
BNO	BNO Presenting at Neuropsychiatric Drug Development Summit		09/11/20	90.97KB	Share

BNO Resignation of Director - M Kaye
31/12/21		178.65KB	Share
BNO Becoming a substantial holder
24/12/21		520.23KB	Share
BNO Change of Director's Interest Notice AF
22/12/21		255.09KB	Share
BNO Change of Director's Interest Notice EDS
22/12/21		284.59KB	Share
BNO Notification regarding unquoted securities - BNO
22/12/21		26.2KB	Share
BNO Change in substantial holding
22/12/21		198.26KB	Share
BNO Bionomics Announces Closing of IPO in the US
21/12/21		106.77KB	Share
BNO Cleansing Notice
20/12/21		140.7KB	Share
BNO Application for quotation of securities - BNO
17/12/21		23.16KB	Share
BNO Proposed issue of securities - BNO
16/12/21		27.84KB	Share
BNO Bionomics Announces Pricing of IPO in the US
16/12/21	PRICE SENSITIVE	108.41KB	Share
BNO Trading Halt
16/12/21	PRICE SENSITIVE	221.5KB	Share
BNO Pause in Trading
16/12/21	PRICE SENSITIVE	114.01KB	Share
BNO Notification of cessation of securities - BNO
14/12/21		22KB	Share
BNO Bionomics Announces Launch of Proposed IPO in the US
14/12/21	PRICE SENSITIVE	186.82KB	Share
BNO 2021 New Constitution
02/12/21		1.2MB	Share
BNO 2021 AGM Results of Meeting
02/12/21		182.45KB	Share
BNO 2021 AGM Executive Chairman's Presentation
02/12/21	PRICE SENSITIVE	929.59KB	Share
BNO Fast Track Designation for BNC210 in Social Anxiety Disorder
01/12/21	PRICE SENSITIVE	194.35KB	Share
BNO Notification of cessation of securities - BNO
30/11/21		21.51KB	Share
BNO BNO Files Registration Statement for Proposed IPO in the US
23/11/21	PRICE SENSITIVE	178.1KB	Share
BNO Update on Possible Capital Distribution
19/11/21	PRICE SENSITIVE	85.19KB	Share
BNO Bionomics Receives ASX Waiver from LR 10.13.5
18/11/21		176.93KB	Share
BNO Section 708A Notice
11/11/21		159.37KB	Share
BNO Application for quotation of securities - BNO
11/11/21		24.68KB	Share
BNO FDA Clears BNC210 Ph2 Social Anxiety Disorder IND (PREVAIL)
01/11/21		209.94KB	Share
BNO 2021 Notice of AGM/Proxy Form
01/11/21		1.64MB	Share
BNO Quarterly Activities/Appendix 4C Cash Flow Report
29/10/21	PRICE SENSITIVE	245.77KB	Share
BNO Jobkeeper Payments Notification
29/10/21		199.15KB	Share
BNO 2021 Corporate Governance Statement and Appendix 4G
29/10/21		669.96KB	Share
BNO 2021 Annual Report
29/10/21		4.09MB	Share
BNO Closing Date for Nomination of Director
14/10/21		172.15KB	Share
BNO Notification of cessation of securities - BNO
07/10/21		21.54KB	Share
BNO BNO prepares BNC210 for start of Phase 2 Acute SAD trial
20/09/21	PRICE SENSITIVE	186.76KB	Share
BNO Cleansing Notice
02/09/21		159.95KB	Share
BNO Application for quotation of securities - BNO
01/09/21		24.83KB	Share
BNO Correction to Appendix 4E
31/08/21	PRICE SENSITIVE	196.94KB	Share
BNO Full Year Statutory Accounts FY2021
25/08/21		1.04MB	Share
BNO Preliminary Final Report FY2021 App 4E and Announcement
25/08/21	PRICE SENSITIVE	262.97KB	Share
BNO BNO Announces Planned Capital Distribution to Shareholders
02/08/21	PRICE SENSITIVE	187.58KB	Share
BNO BNO Announces Plans to Conduct U.S. Initial Public Offering
02/08/21	PRICE SENSITIVE	162.74KB	Share
BNO Quarterly Activities and Cashflow Report
29/07/21	PRICE SENSITIVE	247.97KB	Share
BNO Final Director's Interest Notice
19/07/21		244.37KB	Share
BNO BNO Initiates Phase 2b ATTUNE Study of BNC210 in PTSD
06/07/21	PRICE SENSITIVE	237.02KB	Share
BNO Initial Director's Interest Notice M. Davies
01/07/21		157.83KB	Share
BNO Notification of cessation of securities - BNO
01/07/21		22.15KB	Share
BNO Executive Chairman - New Employment Agreement
01/07/21		110.48KB	Share
BNO Appointment and Resignation of Director
01/07/21		93.71KB	Share
BNO Change of Telephone Number
18/06/21		91.17KB	Share
BNO Change of Address
07/06/21		92.08KB	Share
BNO Cleansing Notice
04/06/21		149.37KB	Share
BNO Appendix 2A
03/06/21		299.39KB	Share
BNO Corporate Presentation May 2021
25/05/21		2.7MB	Share
BNO Bionomics BNC210 Expansion into Social Anxiety Disorder
10/05/21		158.09KB	Share
BNO Bionomics Announces Early Repayment of Debt
03/05/21	PRICE SENSITIVE	167.1KB	Share
BNO Quarterly Cashflow Report Mar 2021
23/04/21	PRICE SENSITIVE	334.57KB	Share
BNO Change in substantial holding
14/04/21		346.64KB	Share
BNO Appendix 3Y D Wilson
14/04/21		288.96KB	Share
BNO Change in substantial holding
12/04/21		128.96KB	Share
BNO Cleansing Notice - Concurrent Placement
08/04/21		147.77KB	Share
BNO Appendix 2A - Concurrent Placement
08/04/21		298.63KB	Share
BNO Appendix 2A - Entitlement Offer
08/04/21		298.76KB	Share
BNO Change of Company Secretary
08/04/21		113.7KB	Share
BNO Results of Entitlement Offer and Concurrent Placement
06/04/21	PRICE SENSITIVE	174.33KB	Share
BNO Change of Company Secretary
24/03/21		79.57KB	Share
BNO Proposed issue of Securities - BNO
18/03/21		24.44KB	Share
BNO Concurrent Placement with Entitlement Offer to be Conducted
17/03/21	PRICE SENSITIVE	86.39KB	Share
BNO Bionomics Completes Despatch of Entitlement Offer Booklet
16/03/21		89.55KB	Share
BNO BNO at H.C. Wainwright Global Life Sciences Conference
08/03/21		90.51KB	Share
BNO Proposed issue of Securities - BNO
08/03/21		28.05KB	Share
BNO Entitlement Offer Notification to Option Holders
08/03/21		125.43KB	Share
BNO Ineligible Shareholder letter
08/03/21		146.64KB	Share
BNO Bionomics Ltd Entitlement Offer Booklet
08/03/21	PRICE SENSITIVE	419.83KB	Share
BNO Cleansing Notice
08/03/21		83.69KB	Share
BNO Bionomics Ltd Announces Non-Renounceable Entitlement Offer
08/03/21	PRICE SENSITIVE	99.68KB	Share
BNO Change in substantial holding
05/03/21		100.81KB	Share
BNO Change in substantial holding
04/03/21		1.15MB	Share
BNO Appendix 2A
02/03/21		280.51KB	Share
BNO Cleansing Notice
02/03/21		76.78KB	Share
BNO Completion of Placement
02/03/21	PRICE SENSITIVE	86.73KB	Share
BNO Half Yearly Report and Accounts
26/02/21	PRICE SENSITIVE	491.21KB	Share
BNO Change in substantial holding
24/02/21		572.93KB	Share
BNO Positive BNC210 PK Results for Solid Dose Formulation
22/02/21	PRICE SENSITIVE	194.29KB	Share
BNO Bionomics and EmpathBio Joint Feasibility Assessment
17/02/21		143.48KB	Share
BNO Notification of Change in Auditor
12/02/21		86.98KB	Share
BNO Proposed issue of Securities - BNO
09/02/21		24.49KB	Share
BNO $16 Million Capital Raise to Progress BNC210 PTSD Trial
09/02/21	PRICE SENSITIVE	104.81KB	Share
BNO Response to ASX Price Query
05/02/21	PRICE SENSITIVE	263.82KB	Share
BNO Appendix 4C - quarterly
29/01/21	PRICE SENSITIVE	360.92KB	Share
BNO BNC105 / Nivolumab Treatment Completed in Phase 2 Trial
20/01/21		133.92KB	Share
BNO Publication of Positive BNC210 Phase 2a Data in GAD Patients
18/01/21		133.81KB	Share
BNO BNO Presenting at H.C. Wainwright BioConnect 2021 Conference
07/01/21		89.99KB	Share
BNO BNO Initiates 7-Day Dosing Pharmacokinetic Study of BNC210
04/01/21	PRICE SENSITIVE	93.64KB	Share
BNO Lapse of Employee Share Options & Warrants
18/12/20		81.21KB	Share
BNO Appendix 3Y
24/11/20		161.6KB	Share
BNO Final Director's Interest Notice
20/11/20		151.61KB	Share
BNO Results of Meeting
20/11/20		151.86KB	Share
BNO Executive Chairmans 2020 AGM Presentation
20/11/20		805.2KB	Share
BNO Bionomics Licenses Drug Candidate BNC101 to Carina Biotech
19/11/20	PRICE SENSITIVE	127.88KB	Share
BNO BNO Presenting at Neuropsychiatric Drug Development Summit
09/11/20		90.97KB	Share

REFRESH

First 2 3 4 5 6

BIONOMICS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available